Zenas is a clinical-stage global biopharmaceutical company committed to becoming a leader in the development and commercialization of transformative therapies for patients with autoimmune diseases. Our core business strategy combines our experienced leadership team with a disciplined
Director of Biostatistics Watertown, Massachusetts, United States The Director of Biostatistics will lead the statistical strategy, design, and trial-level execution for early-phase oncology clinical trials (Phase I/II). This is a high-impact, trial-focused role responsible for authoring
Medical Director Watertown, Massachusetts, United States Treeline has a robust research pipeline from discovery to clinic, and we are leveraging this for the greatest possible impact for patients. As a clinician and scientist, you will be
Build the Future of Building Automation Service At BCM Controls, were looking for more than someone to manage a service department, were looking for a leader who enjoys developing people, building strong customer relationships, and continuously
Associate Director, Statistical Programming Waltham, Massachusetts At Kailera, we are bold, authentic and committed to our mission of developing therapies that give people the power to transform their lives and elevate their overall health. Rooted in
Job Requirements 7+ years of professional experience in enterprise software development focusing on jBase and Multivalue database systems. Proficiency in SAP data conversion protocols and large-scale legacy-to-modern system integration strategies. Experience with technical data mapping and complex
Clinical Database Analyst Responsible for visualizing clinical trial data in SPOTFIRE for the Analytical Risk-based Monitoring (ARBM) group and for the medical reviewers in the iDARTs application (an internally developed tool for medical review of clinical
Company Description About Bicycle Therapeutics Bicycle Therapeutics is a clinical-stage pharmaceutical company developing a novel class of medicines, referred to as Bicycle® molecules, for diseases that are underserved by existing therapeutics. Bicycle molecules are fully synthetic